Sorry, you need to enable JavaScript to visit this website.

Looking Back on a Strong 2024

Pfizer celebrated our 175th anniversary with a year of transformation—and execution. We take a close look at everything we accomplished in 2024’s Annual Review.

Read the Review Details
Watch Pfizer | Big Game Commercial 2025 | Knock Out on YouTube.

Join Pfizer in the Fight Against Cancer

Nearly 41% of Americans will receive a cancer diagnosis during their lifetime. By understanding their risks, people can take action to help detect it early, when it's most treatable. We’re working with our partners at the American Cancer Society to make this easier than ever.

Read More Details

United by Our Unique and Personal Connections to Cancer

Pfizer recognizes World Cancer Day by sharing personal stories from colleagues impacted by cancer. Each unique story unites us in our purpose – a world where people with cancer live better and longer lives. Nothing is more personal than our goal to outdo cancer.

Read Their Stories Details
Science & Innovation

The Next Era of Decentralized Clinical Trials: The Clinical Trial Anywhere Model

About Pfizer's initiative to make clinical trials more participant-friendly through the decentralized "Clinical Trial Anywhere" model; a suite of solutions like remote sample collection, alternative study conduct locations, home health, and mobile units to reduce the need for in-person visits.
Doctor showing medical data to patient on tablet thumbnail
Science & Innovation

Harnessing the Power of AI to Detect ATTR-CM

Artificial intelligence (AI) has quietly become a part of our daily lives – through personalized recommendations, virtual assistants, or smart devices, we barely notice it anymore.
A young African - American doctor works on HUD or graphic display in front of her, we see her from the waist up in a modern laboratory thumbnail
Science & Innovation

In Search of a New Hemophilia Treatment

Despite significant advancements in hemophilia treatments over the past several decades, balancing management of the disorder while maintaining regular day-to-day activities remains a challenge.
Still from hemophilia video 2 thumbnail

Pfizer Sets New Ambition: Changing a Billion Lives a Year by 2027

An evolution of the previous Purpose Blueprint, implemented in 2019, the Purpose Blueprint 2.0 consists of five “Core Business Principles” and 15 Big Ideas that will drive us in the years to come.

Learn More About Our Blueprint 2.0 Details

An Accord for a Healthier World

Where people live shouldn’t impact the quality of their healthcare and income shouldn’t determine health outcomes.

Learn More About The Accord Details

While we continue to see the devastating impact of the coronavirus pandemic around the world, we’re committed to helping keep people safe and informed. 

More On COVID-19 Details
Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. 

 

Explore RxPathways Details

Starting with Charles Pfizer inventing an almond-flavored antiparasite medicine in 1849, our people have always been innovators and trailblazers, committed to finding the next cure. 

Learn More About Us Details

The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.

Show Your Pfizer Pride!

Shop and share the collection.

All profits from The Pfizer Store will be donated to charity.

 

Shop The Pfizer Collection Details

Sign up for communications from Pfizer

Receive the latest news from Pfizer in our monthly The Breakthrough newsletter and email alerts on a variety of topics.

Sign Up Now Details
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy